Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2013

Apr 3, 2013

5229_dirs_2013-04-03_71610a7d-9b5e-4eaa-b45a-1767dbd14475.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4970B

AstraZeneca PLC

03 April 2013

Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 28 March 2013, the following individuals, who are both persons discharging managerial responsibilities, acquired an interest in the USD0.25 Ordinary Shares or American Depositary Shares (ADSs) of AstraZeneca PLC.  One ADS equals one Ordinary Share.  The interest arises as a result of the arrangements relating to the payment of annual bonuses whereby each individual is required to defer a portion of the bonus earned into shares for a period of three years.  The shares are awarded under the terms of the AstraZeneca Deferred Bonus Plan.  The individuals will become beneficially entitled to these shares on 28 March 2016. Ordinary Shares were awarded at 3254 pence per share. ADSs were awarded at $49.42 per share.

Name Number of Ordinary Shares/ADSs awarded
Mene Pangalos 2,025
Briggs Morrison 1,796

A C N Kemp

Company Secretary

3 April 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUOVORONASRAR